Diabetes Thyroid Hormone Research Institute Profile
Key Indicators
- Authorised Capital ₹ 0.55 M
as on 15-11-2024
- Paid Up Capital ₹ 0.17 M
as on 15-11-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.89 Cr
as on 15-11-2024
- Satisfied Charges ₹ 14.31 Cr
as on 15-11-2024
- Revenue 1.07%
(FY 2023)
- Profit -35.56%
(FY 2023)
- Ebitda 14.59%
(FY 2023)
- Net Worth 6.46%
(FY 2023)
- Total Assets 0.57%
(FY 2023)
About Diabetes Thyroid Hormone Research Institute
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.55 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹4.89 Cr. The company has closed loans amounting to ₹14.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Jain and Rajkumar Bafna serve as directors at the Company.
- CIN/LLPIN
U67120MP1996PTC010807
- Company No.
010807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 1996
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Diabetes Thyroid Hormone Research Institute?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Jain  | Managing Director | 01-Aug-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajkumar Bafna | Director | 31-Mar-2005 | Current |
Financial Performance of Diabetes Thyroid Hormone Research Institute.
Diabetes Thyroid Hormone Research Institute Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.07% increase. The company also saw a substantial fall in profitability, with a 35.56% decrease in profit. The company's net worth moved up by a moderate rise of 6.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diabetes Thyroid Hormone Research Institute?
In 2023, Diabetes Thyroid Hormone Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Jan 2023 | ₹4.89 Cr | Open |
Others Creation Date: 25 Jul 2022 | ₹8.44 M | Satisfied |
Central Bank Of India Creation Date: 21 Feb 2014 | ₹4.45 Cr | Satisfied |
How Many Employees Work at Diabetes Thyroid Hormone Research Institute?
Diabetes Thyroid Hormone Research Institute has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diabetes Thyroid Hormone Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diabetes Thyroid Hormone Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
